Company Directory / pharmaceuticals
PrivateFor profitpharmaceuticalsSouth San Francisco, United States
Cellares
Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.
- Founded
- 2019 7 years ago
- Staff
- 101-250 band, as listed
- Followers
- - on LinkedIn
- Funding
- $355M as listed, currency not stated
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed
Age
7 years old.
Reach
Website ranked #2,345,655 in the world for traffic, about 8k visits a month.
What it does
BiotechnologyLife ScienceManufacturingMedicalTherapeutics
Funding, as listed
$355M currency not stated
- Rounds3
- LatestSeries c, Aug 2023
- Investors9, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Cellares, field by field. Contact details are held but never shown.
The company
- Name
- Cellares
- Type
- For profit
- Status
- Private
- Founded
- 2019
- Founders
- Alex Pesch, Fabian Gerlinghaus, Omar Kurdi
- Industry
- pharmaceuticals
- Categories
- Biotechnology, Life Science, Manufacturing, Medical, Therapeutics
Where
- City
- South San Francisco
- Country
- United States
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach
- Staff band
- 101-250
- Web traffic rank
- #2,345,655
- Monthly web visits
- 8,304
Funding, as listed
- Total
- 355,000,000 (currency not stated)
- Rounds
- 3
- Latest round
- Series c
- Latest round date
- Aug 2023
- Investors
- 9
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Cellares may be growing as it has recently achieved a significant regulatory milestone by gaining cGMP for its Cell Shuttle, which is a critical step in advancing towards clinical applications. Furthermore, the company has secured a substantial $380 million deal with Bristol Myers Squibb, indicating strong financial backing and confidence from a major pharmaceutical entity. Additionally, the establishment of a new facility is a testament to the company's expansion and the positive impact it is expected to have on New Jersey's innovation and life sciences sectors.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
pharmaceuticals in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.